|Articles|June 7, 2017
Chesapeake IRB Announces Acquisition of MaGil IRB
Advertisement
Chesapeake IRB-technology-enabled independent institutional review board (IRB) that serves the clinical research industry-has acquired MaGil IRB.
The acquisition provides Chesapeake with additional AAHRPP-accredited review capacity and more staff, broadening its precense for CROs, pharma companes, and biotech companies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
2
When AI Learns to Speak Every Language: An eCOA Migration Study
3
Using Digital Tools to Enhance Patient-Centric Trials
4
Gilead’s ARTISTRY-2 Trial Shows Bictegravir Lenacapavir Combo Matches Biktarvy in Virologically Suppressed Adults With HIV
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
